Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Scientific Reports|September 28, 2023
Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameterTakashi Tanaka, Kazuhide Takata, Takashi Miyayama, et al.
Anticancer Research|July 26, 2024
Tranilast Inhibits TRPV2 and Suppresses Fibrosis Progression and Weight Gain in a NASH Model MouseTakahiro Nagata, Satoshi Shakado, Eri Yamauchi, et al.
Oncology|September 3, 2020
Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular CarcinomaHideo Kunimoto, Satoshi Shakado, Takashi Tanaka, et al.
Clinical and Molecular Hepatology|November 10, 2018
Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosisKeiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, et al.
Oncology|August 18, 2020
The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same PeriodTakashi Tanaka, Kazuhide Takata, Hideo Kunimoto, et al.
Clinical Journal of Gastroenterology|February 9, 2018
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatisKazuhide Takata, Hiromi Fukuda, Kaoru Umeda, et al.
Internal Medicine (Tokyo, Japan)|February 8, 2023
Two Cases of Rapidly Progressive Fatty Liver Disease due to Pancreatic Exocrine Insufficiency without a History of SurgeryKazuhide Takata, Takahiro Nagata, Keisuke Matsumoto, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|January 28, 2025
Outcome and Prognosis of Invasive Treatment for Hepatocellular Carcinoma in Very Elderly Patients Over 90 Years OldKeiji Yokoyama, Hiroaki Tokushige, Takahiro Nagata, et al.
Nutrients|November 8, 2018
Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus InfectionYi-Ling Ko, Daisuke Morihara, Kumiko Shibata, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2019
Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral AgentsShinjiro Inomata, Akira Anan, Eri Yamauchi, et al.
Pageof 8